Image credit: Jialun Zhu, Shuyu Lin, and Yichao Zhao (I²BL/UCLA)
Engineers at the UCLA Samueli School of Engineering and their colleagues at Stanford School of Medicine have demonstrated that drug levels inside the body can be tracked in real time using a custom smartwatch that analyzes the chemicals found in sweat. This wearable technology could be incorporated into a more personalized approach to medicine — where an ideal drug and dosages can be tailored to an individual.
A study detailing the research was published in Proceedings of the National Academy of Sciences.
In general, medications are prescribed with a ‘one-size-fits-all’ approach — drugs are designed and prescribed based on statistical averages of their effectiveness. There are guidelines for factors such as patients’ weight and age. But in addition to these basic differentiators, our body chemistry constantly changes — depending on what we eat and how much we’ve exercised. And on top of these dynamic factors, every individual’s genetic makeup is unique and hence responses to medications can vary. This affects how fast drugs are absorbed, take effect and get eliminated from an individual.
According to the researchers, current efforts to personalize the drug dosage rely heavily on repeated blood draws at the hospital. The samples are then sent out to be analyzed in central labs. These solutions are inconvenient, time-consuming, invasive and expensive. That is why they are only performed on a small subset of patients and on rare occasions.
“We wanted to create a wearable technology that can track the profile of medication inside the body continuously and non-invasively,” said study leader Sam Emaminejad, an assistant professor of electrical and computer engineering at UCLA. “This way, we can tailor the optimal dosage and timing of the intake for each individual. And using this personalization approach, we can improve the efficacy of the therapeutic treatments.”
Because of their small molecular sizes, many different kinds of drugs end up in sweat, where their concentrations closely reflect the drugs’ circulating levels. That’s why the researchers created a smartwatch, equipped with a sensor that analyzes the sampled tiny droplets of sweat.
The team’s experiment tracked the effect of acetaminophen, a common over-the-counter pain medication, on individuals over the period of a few hours. First, the researchers stimulated sweat glands on the wrist by applying a small electric current, the same technique that Emaminejad’s research group demonstrated in previous wearable technologies.
This allowed the researchers to detect changes in body chemistry, without needing subjects to work up a sweat by exercising. As different drugs each have their own unique electrochemical signature, the sensor can be designed to look for the level of a particular medication at any given time.
“This technology is a game-changer and a significant step forward for realizing personalized medicine,” said study co-author Ronald W. Davis, a professor of biochemistry and genetics at Stanford Medical School. “Emerging pharmacogenomic solutions, which allow us to select drugs based on the genetic makeup of individuals, have already shown to be useful in improving the efficacy of treatments. So, in combination with our wearable solution, which helps us to optimize the drug dosages for each individual, we can now truly personalize our approaches to pharmacotherapy.”
What makes this study significant is the ability to accurately detect a drug’s unique electrochemical signal, against the backdrop of signals from many other molecules that may be circulating in the body and in higher concentrations than the drug, said the study’s lead author Shuyu Lin, a UCLA doctoral student and member of Emaminejad’s Interconnected and Integrated Bioelectronics Lab (I²BL). Emaminejad added that the technology could be adapted to monitor medication adherence and drug abuse.
“This could be particularly important for individuals with mental health issues, where doctors prescribe them prolonged pharmacotherapy treatments,” he said. ” The patients could benefit from such easy-to-use, noninvasive monitoring tools, while doctors could see how the medication is doing in the patient.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Tracking medication levels
- Caster Semenya takes appeal to European court over testosterone levels in female runnerson February 25, 2021 at 7:41 am
Olympic 800m champion Caster Semenya will appeal to the European Court of Human Rights against the restriction of testosterone levels in ...
- Drug executives: Big jump in vaccine supply is coming soonon February 24, 2021 at 2:02 pm
WASHINGTON — Covid-19 vaccine makers told Congress on Tuesday to expect a big jump in the delivery of doses over the coming month, and the companies insist they will be able to provide enough for most ...
- Will This Be The Year Congressional Democrats Rein In High Drug Costs?on February 24, 2021 at 11:12 am
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN’s Prescription Drug Watch roundup.
- 'We do believe we're on track': Drug execs expect most Americans to be inoculated by summeron February 23, 2021 at 1:58 pm
COVID-19 vaccine makers told Congress on Tuesday to expect a big jump in the delivery of doses over the coming month ...
- Dr. Ren Feng Appointed as Chief Scientific Officer of Insilico Medicineon February 22, 2021 at 7:00 am
Insilico Medicine (the "Company"), a global leader in artificial intelligence for drug discovery and biomarker development, today announced the appointment of Dr. Feng ...
Go deeper with Google Headlines on:
Tracking medication levels
Go deeper with Bing News on:
Personalized drug dosage
- Medisafe raises $30 million for predictive AI that reminds people to take their pills – Jawebon February 25, 2021 at 4:19 am
Medisafe, a startup developing a personalized medication management platform designed to help patients stay on top of their prescriptions, today announced that it raised $30 million. The company says ...
- Medisafe raises $30 million for predictive AI that reminds people to take their pillson February 25, 2021 at 4:02 am
Medisafe, a startup developing a platform to promote medication adherence, has raised $30 million in venture capital.
- Quantifying cell death induced by doxorubicin, hyperthermia or HIFU ablation with flow cytometryon February 23, 2021 at 2:22 am
In the clinical use of focused ultrasound (FUS) or high intensity FUS (HIFU) devices for conventional cancer ablation in solid organs, localised coagulative necrosis is the desired end result. As with ...
- PMC Group International Announces Acquisition of Copperhead Chemical Companyon February 23, 2021 at 1:31 am
PMC Group International, Inc., which is an independent arm of PMC Group Companies, announced the acquisition of Cobra Investments Management Inc. and its two subsidiaries, Copperhead Chemical Company ...
- Two Distinct Pathways Leading to the Development of Septic Shock Pave the Way For Personalized Medicine in Sepsison February 18, 2021 at 1:49 am
Researchers have published new insights into the causes of mortality in sepsisLoss of endothelial function is induced through two different pathophysiological processes and is a major driver of septic ...